Vaccine effectiveness against SARS-CoV-2 variants in adolescents from 15 to 90 days after second dose: a population-based test-negative case-control study
To estimate the vaccine effectiveness (VE) against hospitalization and severe illness in adolescents due to infection with SARS-CoV-2 variants (gamma, delta, and omicron).
source https://www.jpeds.com/article/S0022-3476(22)00861-7/fulltext?rss=yes
source https://www.jpeds.com/article/S0022-3476(22)00861-7/fulltext?rss=yes
Comments
Post a Comment